James Tursi

James Patrick Tursi is currently Director at Ideal Image Development (Delaware), Inc. since 2021, Director at Ideal Image Development Corp.
since 2021, Independent Director at MetaVia, Inc. since 2023, and Executive VP-Global Research & Development at Endo International Plc since 2022.
Former roles include Independent Director at Agile Therapeutics, Inc. from 2014 to 2022; Director-Medical Affairs at GlaxoSmithKline Biologicals SA from 2006 to 2009; Senior Medical Director-Medical Affairs at Procter & Gamble Pharmaceuticals, Inc. from 2004 to 2006; Chief Medical Officer & Executive Vice President at Antares Pharma, Inc. from 2018 to 2020; Chief Medical Officer at POZEN, Inc. from 2015 to 2018; Chief Medical Officer at Auxilium Pharmaceuticals LLC from 2011 to 2015; Chief Medical Officer at Innocoll AG in 2015; Executive Vice President-Research & Development at Antares Pharma, Inc. from 2018 to 2020; and other Chief Medical Officer and Chief Scientific Officer roles at Innocoll Pharmaceuticals Ltd., Old API Wind-down Ltd., Aralez, Inc., and Ferring Pharmaceuticals, Inc. Education includes undergraduate studies at Ursinus College, graduate studies at Drexel University College of Medicine, and a doctorate from Perelman School of Medicine.